CAR T-cell therapies show promise, immune reset in multiple diseases at EULAR 2025

Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent B-cell depletion and recovery, as well as improved disease activity, said a presenter at the EULAR 2025 Congress.“We’ve seen already today another presentation on CAR-T therapies and related approaches showing great promise in deep B-cell depletion, leading to